サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1314872

尿路結石症管理デバイス市場：治療タイプ別、エンドユーザー別-2023-2030年の世界予測

Urolithiasis Management Devices Market by Treatment Type, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
尿路結石症管理デバイス市場：治療タイプ別、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

尿路結石症管理デバイスの世界市場は、2023年にCAGR 10.73%で5億188万米ドルが予測され、2030年には10億2,591万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の尿路結石症管理デバイス市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客ベース、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.尿路結石症管理デバイスの世界市場規模および予測は？

2.予測期間中、世界の尿路結石症管理デバイス市場を形成するCOVID-19の阻害要因と影響は？

3.尿路結石症管理デバイスの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.尿路結石症管理デバイスの世界市場における競争戦略は？

5.尿路結石症管理デバイスの世界市場における技術動向と規制の枠組みは？

6.尿路結石症管理デバイスの世界市場における主要ベンダーの市場シェアは？

7.尿路結石症管理デバイスの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 尿路結石の発生率の増加と高齢者人口の増加
      • 非侵襲手術の傾向の高まりと低侵襲技術への意識の高まり
    • 抑制要因
      • これらの装置と手順は入手可能性が限られており、コストが高い
    • 機会
      • 病院部門における革新的なテクノロジーの採用の増加
      • 非公開会社からの投資の急増と政府の有利な取り組み
    • 課題
      • 尿閉塞や腎臓周囲の出血などの治療の副作用の可能性
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 尿路結石症管理デバイス市場治療タイプ別

  • 体外衝撃波砕石術
  • 体内砕石術
  • 経皮的腎結石切開術

第7章 尿路結石症管理デバイス市場：エンドユーザー別

  • 外来手術センター
  • 病院とクリニック

第8章 南北アメリカの尿路結石症管理デバイス市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の尿路結石症管理デバイス市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの尿路結石症管理デバイス市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. UROLITHIASIS MANAGEMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2030 (%)
  • FIGURE 5. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 6. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. UROLITHIASIS MANAGEMENT DEVICES MARKET DYNAMICS
  • FIGURE 8. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. UROLITHIASIS MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 9. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 98. UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 99. UROLITHIASIS MANAGEMENT DEVICES MARKET LICENSE & PRICING
目次
Product Code: MRR-ED54C46E901D

The Global Urolithiasis Management Devices Market is forecasted to grow significantly, with a projected USD 501.88 million in 2023 at a CAGR of 10.73% and expected to reach a staggering USD 1,025.91 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Urolithiasis Management Devices Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Urolithiasis Management Devices Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Treatment Type, market is studied across Extracorporeal Shock Wave Lithotripsy, Intracorporeal Lithotripsy, and Percutaneous Nephrolithotomy. The Percutaneous Nephrolithotomy is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals & Clinics. The Hospitals & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Urolithiasis Management Devices Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Urolithiasis Management Devices Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Urolithiasis Management Devices Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Urolithiasis Management Devices Market?

4. What is the competitive strategic window for opportunities in the Global Urolithiasis Management Devices Market?

5. What are the technology trends and regulatory frameworks in the Global Urolithiasis Management Devices Market?

6. What is the market share of the leading vendors in the Global Urolithiasis Management Devices Market?

7. What modes and strategic moves are considered suitable for entering the Global Urolithiasis Management Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Urolithiasis Management Devices Market, by Treatment Type, 2022 vs 2030
  • 4.3. Urolithiasis Management Devices Market, by End-User, 2022 vs 2030
  • 4.4. Urolithiasis Management Devices Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of urinary stones and increasing elderly population
      • 5.1.1.2. Rising proclivity for non-invasive surgeries and awareness of minimally invasive techniques
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability and high cost of these devices and procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing adoption of innovative technologies in the hospital sector
      • 5.1.3.2. Surge in investment from private companies and favorable government initiatives
    • 5.1.4. Challenges
      • 5.1.4.1. Probable side effects of the treatment such as blockage of urine and bleeding around kidneys
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Urolithiasis Management Devices Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Extracorporeal Shock Wave Lithotripsy
  • 6.3. Intracorporeal Lithotripsy
  • 6.4. Percutaneous Nephrolithotomy

7. Urolithiasis Management Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals & Clinics

8. Americas Urolithiasis Management Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Urolithiasis Management Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Urolithiasis Management Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing